Bangladesh getting India’s export ‘Covishield’ as per agreement
Published: 10:49 AM, 23 January 2021
Covid-19 vaccine ‘Covishield’; Photo: Collected
The Indian government has approved the export of the Covid-19 vaccine ‘Covishield’, manufactured by Serum Institute of India, invented by Oxford-AstraZeneca. Bangladesh will get the first shipment of this vaccine soon as per the agreement.
Anurag Srivastava, a spokesperson for the Indian Ministry of External Affairs, told reporters on Friday evening that India would supply coronavirus vaccines to friendly Bangladesh, Saudi Arabia, South Africa, Morocco and Myanmar in phases from next week and month as per the agreement.
The vaccines would be supplied to friendly countries in phases as per the agreement, keeping the required number of vaccines to meet the domestic demand of the country, Srivastava said while responding to query from various media outlets.
In response to another query, he said “the vaccine would be provided on a G2G, G2B, and B2B basis.”
20 lakh doses of Covid-19 vaccine have been sent to Bangladesh, 10 lakh to Nepal, 1.5 lakh to Bhutan and 1 lakh to Maldives. Besides, 15 lakh doses of vaccine are being given to Myanmar as promised, Anurag Srivastava added.
Indian Foreign Secretary Harsh Vardhan Shringla told reporters that his country had started supplying the Covid-19 vaccine on a commercial basis from Friday as promised by Prime Minister Narendra Modi.